论文信息 - ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma - 字舞流文

ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma

M. Falconi | G. Capurso | G. Guarneri | D. Tamburrino

[1] M. Falconi,et al. Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? , 2020, Annals of Surgical Oncology.

[2] P. Elwood,et al. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies , 2016, PloS one.

[3] M. Malafa,et al. Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature , 2016, PloS one.

[4] Bechien U. Wu,et al. The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis , 2015, PloS one.

[5] P. Muti,et al. Meta‐analysis: the use of non‐steroidal anti‐inflammatory drugs and pancreatic cancer risk for different exposure categories , 2007, Alimentary pharmacology & therapeutics.